V. Gorbounova

670 citations
5 papers · 533 · 1 hit paper · h-index 2

Impact in

    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
    • Gastric Cancer Management and Outcomes
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • Cancer Immunotherapy and Biomarkers

Papers in

V. Gorbounova

3 papers receiving 506 citations

V. Gorbounova's Hit Papers

Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL) 2010 · 529 citations
5290+5+10Years since publication100200300400500

Peers

V. Gorbounova
Comparison fields: 5 of 45
  • Pulmonary and Respiratory Medicine 303
  • Oncology 231
  • Cancer Research 70
  • Hepatology 30
  • Pathology and Forensic Medicine 35
Replace N. B. Leighl with:
N. B. Leighl United States
Marco Brugia Italy
Hongming Pan China
Jang Ho Cho South Korea
Jesper Andreas Palshof Denmark
Jin‐Ji Yang China
Michela Frisinghelli Italy
Adel Zaatar Malaysia
S. Bota France
Xiaoling Ou United Kingdom
V. Gorbounova relative to N. B. Leighl United States N. B. Leighl's profile →
Citations per field
00.5×1.5×
N. B. Leighl · 1×
Citations per year

Countries citing papers authored by V. Gorbounova

Since Specialization
Citations

This map shows the geographic impact of V. Gorbounova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Gorbounova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Gorbounova more than expected).

Fields of papers citing papers by V. Gorbounova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Gorbounova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Gorbounova. The network helps show where V. Gorbounova may publish in the future.

Co-authors

The 21 scholars most cited alongside V. Gorbounova, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with V. Gorbounova Line = papers co-authored together V. Gorbounova links everyone, so they are left out of the graph.

All Works

5 of 5 papers shown
#Work
1
Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)
Hit paper breakdown →
2010529
2 20122
3 19981
4 20041
5 20120

About V. Gorbounova

V. Gorbounova is a scholar working on Oncology, Reproductive Medicine, Cancer Research, Neurology and Endocrinology, Diabetes and Metabolism, having authored 5 papers that have together received 533 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (1 paper), Brain Metastases and Treatment (1 paper), Breast Cancer Treatment Studies (1 paper), Ovarian cancer diagnosis and treatment (1 paper), Cancer Treatment and Pharmacology (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper), Neuroendocrine Tumor Research Advances (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (303 citations), Oncology (231 citations), Cancer Research (70 citations), Hepatology (30 citations) and Pathology and Forensic Medicine (35 citations). V. Gorbounova has collaborated with scholars based in Russia, Germany and Poland. Frequent co-authors include Martin Reck, N. B. Leighl, C. Manegold, Venice Rosalie Archer, Petr Zatloukal, Vera Hirsh, Norman C. Moore, Joachim von Pawel, Rodryg Ramlau and Jörg Michael Mezger. Their work appears in journals such as Annals of Oncology, Cancer Cell International and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact